Slowing the curve: a single-arm meta-analysis of mFARS outcomes following omaveloxolone treatment in Friedreich ataxia.

BMJ Neurol Open · 2026 · PMC13202156 · PMID 42206098

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantp<0.00001actually significant

Subgroup difference The test for subgroup differences was highly significant (χ2=41.18, df=1, p<0.00001), with I2=97.6% for the difference between subgroups.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.